Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-κB pathway

Apoptosis

Volumn 14, Issue 6, 2009, Pages 788-795

  Grimaldo, Sammy ^b,c   Tian, Fang ^b,c   Li, Lu Yuan ^a  

^a NANKAI UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Combination therapy; Cytokine; TNF; VEGI

Indexed keywords

4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; CURCUMIN; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SMALL INTERFERING RNA; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SENSITIZATION;

ANIMALS; APOPTOSIS; CATTLE; ENDOTHELIAL CELLS; I-KAPPA B KINASE; NF-KAPPA B; PROTEIN KINASE INHIBITORS; RNA, SMALL INTERFERING; SMALL MOLECULE LIBRARIES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

BOVINAE;

EID: 67349128589     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-009-0351-9     Document Type: Article

References (26)

1. PA Baeuerle D Baltimore 1989 A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB Genes Dev 3 1689 1698 10.1101/gad.3.11.1689
2. SJ Baker EP Reddy 1998 Modulation of life and death by the TNF receptor superfamily Oncogene 17 3261 3270 10.1038/sj.onc.1202568 (Pubitemid 29043978)
3. AA Beg WC Sha RT Bronson S Ghosh D Baltimore 1995 Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B Nature 376 167 170 10.1038/376167a0
4. JR Burke MA Pattoli KR Gregor PJ Brassil JF MacMaster KW McIntyre X Yang VS Iotzova W Clarke J Strnad Y Qiu FC Zusi 2003 BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice J Biol Chem 278 1450 1456 10.1074/jbc.M209677200 (Pubitemid 36801370)
5. J Cai R Wei J Cheng 2008 Preparation and characterization of a novel chimeric protein VEGI-CTT in Escherichia coli J Biomed Biotechnol 2008 564969 10.1155/2008/564969
6. X Dolcet D Llobet J Pallares X Matias-Guiu 2005 NF-kB in development and progression of human cancer Virchows Arch 446 475 482 10.1007/s00428-005-1264-9 (Pubitemid 40884279)
7. N Ferrara KJ Hillan HP Gerber W Novotny 2004 Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat Rev Drug Discov 3 391 400 10.1038/nrd1381 (Pubitemid 38618122)
8. U Gaur BB Aggarwal 2003 Regulation of proliferation, survival and apoptosis by members of the TNF superfamily Biochem Pharmacol 66 1403 1408 10.1016/S0006-2952(03)00490-8 (Pubitemid 38373326)
9. V Haridas A Shrivastava J Su GL Yu J Ni D Liu SF Chen Y Ni SM Ruben R Gentz BB Aggarwal 1999 VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth Oncogene 18 6496 6504 10.1038/sj.onc.1203059
10. W Hou D Medynski S Wu X Lin LY Li 2005 VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth Clin Cancer Res 11 5595 5602 10.1158/1078-0432.CCR-05-0384 (Pubitemid 41060838)
11. M Karin A Lin 2002 NF-kappaB at the crossroads of life and death Nat Immunol 3 221 227 10.1038/ni0302-221 (Pubitemid 34213423)
12. S Kim L Zhang 2005 Identification of naturally secreted soluble form of TL1A, a TNF-like cytokine J Immunol Methods 298 1 8 10.1016/j.jim.2004.12.019 (Pubitemid 40545088)
13. J Kucharczak MJ Simmons Y Fan C Gelinas 2003 To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis Oncogene 22 8961 8982 10.1038/sj.onc.1207230 (Pubitemid 38121698)
14. TS Migone J Zhang X Luo L Zhuang C Chen B Hu JS Hong JW Perry SF Chen JX Zhou YH Cho S Ullrich P Kanakaraj J Carrell E Boyd HS Olsen G Hu L Pukac D Liu J Ni S Kim R Gentz P Feng PA Moore SM Ruben P Wei 2002 TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator Immunity 16 479 492 10.1016/S1074-7613(02)00283-2 (Pubitemid 34260924)
15. C Nakanishi M Toi 2005 Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs Nat Rev Cancer 5 297 309 10.1038/nrc1588 (Pubitemid 40488635)
16. MH Pan SY Lin-Shiau JK Lin 2000 Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages Biochem Pharmacol 60 1665 1676 10.1016/S0006-2952(00)00489-5
17. M Romagnoli G Desplanques S Maiga S Legouill M Dreano R Bataille S Barille-Nion 2007 Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL Clin Cancer Res 13 6010 6018 10.1158/1078-0432.CCR-07-0140 (Pubitemid 350075056)
18. G Sa T Das 2008 Anti cancer effects of curcumin: cycle of life and death Cell Div 3 14 10.1186/1747-1028-3-14
19. S Shankar S Ganapathy Q Chen RK Srivastava 2008 Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis Mol Cancer 7 16 10.1186/1476-4598-7-16
20. KB Tan J Harrop M Reddy P Young J Terrett J Emery G Moore A Truneh 1997 Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells Gene 204 35 46 10.1016/S0378-1119(97)00509-X (Pubitemid 28022168)
21. F Tian S Grimaldo M Fujita J Cutts NL Vujanovic LY Li 2007 The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation J Immunol 179 3742 3751
22. J Vakkila RA DeMarco MT Lotze 2004 Imaging analysis of STAT1 and NF-kappaB translocation in dendritic cells at the single cell level J Immunol Methods 294 123 134 10.1016/j.jim.2004.09.007 (Pubitemid 39626597)
23. CR Yang SL Hsieh CM Teng FM Ho WL Su WW Lin 2004 Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action Cancer Res 64 1122 1129 10.1158/0008-5472.CAN-03-0609 (Pubitemid 38176919)
24. J Yu S Tian L Metheny-Barlow LJ Chew AJ Hayes H Pan GL Yu LY Li 2001 Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor Circ Res 89 1161 1167 10.1161/hh2401.101909 (Pubitemid 34627874)
25. Y Zhai J Ni GW Jiang J Lu L Xing C Lincoln KC Carter F Janat D Kozak S Xu L Rojas BB Aggarwal S Ruben LY Li R Gentz GL Yu 1999 VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo FASEB J 13 181 189 (Pubitemid 29038287)
26. Y Zhai J Yu L Iruela-Arispe WQ Huang Z Wang AJ Hayes J Lu G Jiang L Rojas ME Lippman J Ni GL Yu LY Li 1999 Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily Int J Cancer 82 131 136 10.1002/(SICI)1097-0215(19990702)82:1<131::AID-IJC22>3. 0.CO;2-O (Pubitemid 29266118)